세계의 치과용 마취제 시장 : 약물 유형별, 투여 경로별, 최종사용자별, 지역별 - 예측(-2030년)

The global dental anesthetics market is projected to reach USD 1.80 billion by 2030 from USD 1.48 billion in 2025, at a CAGR of 4.0% during the forecast period.

The global market for dental anesthetics is expanding due to a rising incidence of dental issues, which has led to an increase in dental procedures. Furthermore, there is greater awareness of the importance of oral health and cosmetic dentistry, prompting more individuals to seek dental treatments. Improved income levels and enhanced healthcare infrastructure in many regions make dental care more accessible. Additionally, the growing elderly population is expected to drive up demand for these services. However, during the projected period, challenges such as a shortage of dental practitioners and limited insurance coverage for dental procedures may hinder market growth to some extent.

"Articaine is expected to grow at the highest CAGR during the forecast period."

Articaine is projected to experience the highest CAGR during the forecast period due to its numerous advantages over other types of anesthetics. Unlike other amide anesthetics that contain a benzene ring, articaine features a thiophene ring, which leads to increased lipid solubility and improved penetration into tissues and nerve membranes. This enhanced diffusion through both hard and soft tissues makes articaine particularly effective for mandibular infiltrations, where nerve blocks are often required with other anesthetics. Consequently, dentists find that articaine performs better in areas with dense bone structures. Additionally, various studies have confirmed its safety profile when used appropriately, even among elderly and pediatric patient populations. These advantages contribute to the growing popularity of articaine and support its market expansion.

"The topical anesthetics segment is expected to grow at the highest CAGR in the dental anesthetics market, by route of administration."

The topical anesthetics market is projected to experience the highest growth in the dental anesthetics market, driven by their widespread use in standard procedures, ease of application, non-invasiveness, and ability to provide quick surface anesthesia. Dentists increasingly utilize new technologies such as gels, metered-dose sprays, and patches. Additionally, the introduction of needle-free anesthesia and the availability of topical anesthetics in various flavors contribute to their increased adoption. Although topical anesthetics are limited by their short duration of action, their reliability and broad range of applications continue to fuel market growth.

"Based on end users, the dental clinics segment is expected to dominate the dental anesthetics market during the forecast period."

The demand for dental anesthetics is primarily driven by the growth of dental clinics in developing regions of Latin America and the Asia Pacific. As dental services become more accessible in countries such as Vietnam, Indonesia, and India, a greater number of patients are seeking surgeries that require effective pain management. Key factors contributing to the expansion of dental clinics include rising incomes among the middle class, urbanization, and an increasing awareness of oral health. Consequently, there is a growing need for reliable topical and local anesthetics, as more dental clinics now offer restorative and cosmetic procedures.

"The Asia Pacific is expected to register the highest CAGR in the dental anesthetics market during the forecast period."

The dental anesthetics market in the Asia Pacific region is expected to grow at the highest CAGR due to several factors that reflect the changing landscape of healthcare. The rising prevalence of dental infections and greater awareness of oral health drive the demand for dental procedures. Additionally, the region's large and aging population significantly contributes to increased healthcare spending, which boosts the need for easily accessible and patient-friendly treatment options. Improvements in healthcare infrastructure, higher disposable incomes, and advancements in dental anesthetics will also likely fuel growth in the Asia Pacific dental anesthetics market.

A summary of the main supply-side participants in the dental anesthetics market is provided below for this report:

• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (20%), D-level Executives (35%), and Others (45%)
• By Region: North America (25%), Europe (23%), Asia Pacific (28%), Latin America (17%), Middle East & Africa (7%)

The prominent players in the global dental anesthetics market are Septodont Holding (France), DENTSPLY SIRONA (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), DFL Industria e Comercio S/A (Brazil), Ultradent Products Inc. (US), Hikma Pharmaceuticals Plc (UK), Clarben Laboratories (Spain), New Stetic S.A (Colombia), Primex Pharmaceuticals (Switzerland), Keystone Industries (US), Centrix, Inc. (US), GC SHOWAYAKUHIN CORPORATION (Japan), DMG America LLC (US), Zeyco (Mexico), Zymeth Pharmaceutical (India), Cetylite, Inc. (US), ICPA Health Products Limited (India), Crosstex International, Inc. (US), Young Innovations, Inc. (US), Mark3 (Cargus International, Inc.) (US), J.Morita Corp. (Japan), Kulzer GmbH (Germany), and Integra Lifesciences Corporation (US).

Research Coverage

The market study focuses on the dental anesthetics market across various segments. Its purpose is to estimate the market size and growth potential across different categories, including drug type, route of administration, end user, and geographic region. Additionally, the study includes a comprehensive competitive analysis of the key players in the market, along with their company profiles. This analysis features important observations regarding their product offerings, recent developments, and key strategies in the market.

Reasons to Buy the Report

The report provides valuable information for market leaders and new entrants in the dental anesthetics market, offering approximate revenue figures for both the overall market and its subsegments. It enables stakeholders to understand the competitive landscape, which can help them better position their businesses and develop effective go-to-market strategies. Additionally, the report offers insights into the current state of the market, including critical drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (increasing patient pool for dental treatments, increasing demand for advanced cosmetic dental procedures, and technological advancements in anesthetic delivery), restraints (potential adverse effects), opportunities (rising number of DSOs and growing private equity investments, emerging markets, and growing dental tourism) and challenges (dearth of trained dental practitioners and needle phobia).
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global dental anesthetics market. The report analyzes this market by drug type, route of administration, end user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global dental anesthetics market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by drug type, route of administration, end user, and region.
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global dental anesthetics market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 UNIT CONSIDERED
• 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 SCOPE-RELATED LIMITATIONS
  • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 DENTAL ANESTHETICS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION AND COUNTRY (2024)
• 4.3 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 DENTAL ANESTHETICS MARKET: REGIONAL MIX
• 4.5 DENTAL ANESTHETICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing patient pool for dental treatments
      • 5.2.1.1.1 Dental caries and other dental disorders
      • 5.2.1.1.2 Geriatric population and edentulism
      • 5.2.1.1.3 Periodontal diseases
      • 5.2.1.1.4 Changing lifestyles and unhealthy food habits
    • 5.2.1.2 Increasing demand for advanced cosmetic dental procedures
    • 5.2.1.3 Technological advancements in anesthetic delivery
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Potential adverse effects
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising number of DSOs and growing private equity investments
    • 5.2.3.2 Emerging markets
    • 5.2.3.3 Growing dental tourism
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Dearth of trained dental practitioners
    • 5.2.4.2 Needle phobia
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.3.2 BARGAINING POWER OF SUPPLIERS
  • 5.3.3 BARGAINING POWER OF BUYERS
  • 5.3.4 THREAT OF SUBSTITUTES
  • 5.3.5 THREAT OF NEW ENTRANTS
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4.2 REGULATORY LANDSCAPE
• 5.5 INDUSTRY TRENDS
  • 5.5.1 METERED SPRAY SYSTEMS
  • 5.5.2 JET INJECTION SYSTEMS
• 5.6 REIMBURSEMENT SCENARIO
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Vasoconstrictors
    • 5.7.1.2 Buffering agents
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Computer-controlled local anesthetic delivery (CCLAD) systems
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Reversal agents
• 5.8 KEY CONFERENCES & EVENTS, 2025-2026
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION
  • 5.9.2 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020-2024
  • 5.10.2 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020-2024
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS FOR DENTAL ANESTHETICS
  • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL ANESTHETICS MARKET
• 5.12 VALUE CHAIN ANALYSIS
• 5.13 ECOSYSTEM ANALYSIS
• 5.14 SUPPLY CHAIN ANALYSIS
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 CASE STUDY 1: ORAQIX TOPICAL ANESTHETIC SIGNIFICANTLY REDUCED PAIN DURING SRP, ENHANCING COMFORT AND PATIENT ACCEPTANCE OF PERIODONTAL THERAPY
  • 5.15.2 CASE STUDY 2: PROCAINE HYDROCHLORIDE PROVIDES SAFE DENTAL ANESTHESIA FOR PATIENT WITH LIDOCAINE ALLERGIES AND SEVERE PHOBIA
  • 5.15.3 CASE STUDY 3: COMPUTERIZED ANESTHESIA SYSTEM AND PATIENT EDUCATION REDUCE DENTAL ANXIETY IN EXTRACTION PROCEDURES
• 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 BUYING CRITERIA
• 5.18 ADJACENT MARKET ANALYSIS
• 5.19 UNMET NEEDS/END-USER EXPECTATIONS
• 5.20 IMPACT OF AI/GENERATIVE AI ON DENTAL ANESTHETICS MARKET
• 5.21 IMPACT OF 2025 US TARIFF - OVERVIEW
  • 5.21.1 INTRODUCTION
  • 5.21.2 KEY TARIFF RATES
  • 5.21.3 PRICE IMPACT ANALYSIS
  • 5.21.4 IMPACT ON END-USER INDUSTRIES

6 DENTAL ANESTHETICS MARKET, BY DRUG TYPE

• 6.1 INTRODUCTION
• 6.2 LIDOCAINE
  • 6.2.1 RAPID ONSET AND VERSATILE FORMULATIONS TO DRIVE MARKET
• 6.3 MEPIVACAINE
  • 6.3.1 UPTAKE IN PEDIATRIC & GERIATRIC POPULATIONS TO FUEL MARKET
• 6.4 ARTICAINE
  • 6.4.1 IDEAL CHOICE FOR EXTENDED SURGICAL PROCEDURES TO PROPEL MARKET
• 6.5 BUPIVACAINE
  • 6.5.1 PROVISION OF EFFECTIVE POST-OPERATIVE PAIN RELIEF TO SUPPORT MARKET GROWTH
• 6.6 PRILOCAINE
  • 6.6.1 LOWER TOXICITY PROFILE TO FUEL UPTAKE
• 6.7 OTHER DRUG TYPES

7 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION

• 7.1 INTRODUCTION
• 7.2 TOPICAL ANESTHETICS
  • 7.2.1 GROWING PATIENT PREFERENCE FOR NEEDLE-FREE ALTERNATIVES TO BOOST DEMAND
• 7.3 INJECTABLE ANESTHETICS
  • 7.3.1 HIGH PRECISION AND EFFECTIVENESS TO PROPEL MARKET
• 7.4 SYRINGES
  • 7.4.1 ADVANCEMENTS IN SYRINGE DESIGN TO FUEL MARKET
• 7.5 NEEDLES
  • 7.5.1 RISING FOCUS ON INFECTION CONTROL AND PATIENT COMFORT TO SUPPORT MARKET GROWTH

8 DENTAL ANESTHETICS MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 ABILITY TO PURCHASE ADVANCED DENTISTRY EQUIPMENT TO DRIVE MARKET
• 8.3 DENTAL CLINICS
  • 8.3.1 RISING DEMAND FOR COSMETIC & RESTORATIVE DENTAL PROCEDURES TO PROPEL MARKET
• 8.4 OTHER END USERS

9 DENTAL ANESTHETICS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 EUROPE
  • 9.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.2.2 GERMANY
    • 9.2.2.1 Favorable government policies for reimbursement to expedite growth
  • 9.2.3 ITALY
    • 9.2.3.1 Rising adoption of digital dentistry techniques to augment growth
  • 9.2.4 SPAIN
    • 9.2.4.1 Presence of well-established dental healthcare infrastructure to foster growth
  • 9.2.5 FRANCE
    • 9.2.5.1 Favorable distribution network and reimbursement scenario to aid growth
  • 9.2.6 UK
    • 9.2.6.1 Booming geriatric population to stimulate growth
  • 9.2.7 REST OF EUROPE
• 9.3 NORTH AMERICA
  • 9.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.3.2 US
    • 9.3.2.1 High per capita income and quality of treatment to support growth
  • 9.3.3 CANADA
    • 9.3.3.1 Rising healthcare expenditure to sustain growth
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 SOUTH KOREA
    • 9.4.2.1 Growing elderly population to fuel market
  • 9.4.3 JAPAN
    • 9.4.3.1 Surge in age-related dental issues to promote growth
  • 9.4.4 CHINA
    • 9.4.4.1 Shift in demographic trend to accelerate growth
  • 9.4.5 INDIA
    • 9.4.5.1 Growing cosmetic dentistry sector to fuel market
  • 9.4.6 AUSTRALIA
    • 9.4.6.1 Increasing access to dental services to favor growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Booming dental tourism to contribute to growth
  • 9.5.3 ARGENTINA
    • 9.5.3.1 Growing focus on oral health to propel market
  • 9.5.4 MEXICO
    • 9.5.4.1 Affordable dental care costs to amplify growth
  • 9.5.5 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GROWING FOCUS ON UNDERSERVED AREAS TO BOOST MARKET
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 INCREASING NUMBER OF PUBLIC CAMPAIGNS AND EDUCATION PROGRAMS TO DRIVE MARKET
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL ANESTHETICS MARKET
• 10.3 MARKET SHARE ANALYSIS
• 10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.4.1 STARS
  • 10.4.2 EMERGING LEADERS
  • 10.4.3 PERVASIVE PLAYERS
  • 10.4.4 PARTICIPANTS
  • 10.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.4.5.1 Company footprint
    • 10.4.5.2 Region footprint
    • 10.4.5.3 Drug type footprint
    • 10.4.5.4 Route of administration footprint
• 10.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.5.1 PROGRESSIVE COMPANIES
  • 10.5.2 RESPONSIVE COMPANIES
  • 10.5.3 DYNAMIC COMPANIES
  • 10.5.4 STARTING BLOCKS
  • 10.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.5.5.1 Detailed list of key startups/SMEs
    • 10.5.5.2 Competitive benchmarking of key startups/SMEs
• 10.6 COMPANY VALUATION & FINANCIAL METRICS
  • 10.6.1 FINANCIAL METRICS
  • 10.6.2 COMPANY VALUATION
• 10.7 BRAND/PRODUCT COMPARISON
• 10.8 COMPETITIVE SCENARIO
  • 10.8.1 PRODUCT LAUNCHES
  • 10.8.2 DEALS
  • 10.8.3 EXPANSIONS
  • 10.8.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 SEPTODONT HOLDING
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products/Services/Solutions offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 DENTSPLY SIRONA
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products/Services/Solutions offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 PIERREL
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products/Services/Solutions offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches
      • 11.1.3.3.2 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 HUONS GLOBAL
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products/Services/Solutions offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Expansions
      • 11.1.4.3.2 Other developments
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 NORMON
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products/Services/Solutions offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Right to win
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses & competitive threats
  • 11.1.6 DFL INDUSTRIA E COMERCIO S/A
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products/Services/Solutions offered
  • 11.1.7 ULTRADENT PRODUCTS INC.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products/Services/Solutions offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
      • 11.1.7.3.2 Expansions
      • 11.1.7.3.3 Other developments
  • 11.1.8 PRIMEX PHARMACEUTICALS
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products/Services/Solutions offered
  • 11.1.9 KEYSTONE INDUSTRIES
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products/Services/Solutions offered
  • 11.1.10 CLARBEN LABORATORIES
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products/Services/Solutions offered
  • 11.1.11 HIKMA PHARMACEUTICALS PLC
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products/Services/Solutions offered
  • 11.1.12 ZEYCO
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products/Services/Solutions offered
  • 11.1.13 NEW STETIC S.A.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products/Services/Solutions offered
  • 11.1.14 CETYLITE, INC.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products/Services/Solutions offered
  • 11.1.15 ICPA HEALTH PRODUCTS LIMITED
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products/Services/Solutions offered
• 11.2 OTHER PLAYERS
  • 11.2.1 CENTRIX, INC.
  • 11.2.2 ZYMETH PHARMACEUTICAL
  • 11.2.3 DMG AMERICA LLC
  • 11.2.4 GC SHOWAYAKUHIN CORPORATION
  • 11.2.5 YOUNG INNOVATIONS, INC.
  • 11.2.6 CROSSTEX INTERNATIONAL, INC.
  • 11.2.7 MARK3 (CARGUS INTERNATIONAL, INC.)
  • 11.2.8 J. MORITA CORP.
  • 11.2.9 KULZER GMBH
  • 11.2.10 INTEGRA LIFESCIENCES CORPORATION

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS